Kevin Hykes is the President and Chief Executive Officer at CVRx, Inc., a medical device company focused on developing innovative solutions for patients with cardiovascular diseases. With a strong background in the medical device industry, Hykes has been instrumental in guiding CVRx through various stages of growth and development. Prior to joining CVRx, he held leadership positions at several prominent medical device companies, including St. Jude Medical, where he served as the President of the Cardiovascular and Ablation Technologies Division. Under Hykes' leadership, CVRx has made significant strides in advancing its flagship product, the Barostim Neo system, which is designed to treat heart failure through neuromodulation. His strategic vision and deep understanding of the market have been crucial in navigating the company through the complex regulatory landscape and securing approvals for the Barostim system in various countries. Hykes has also been a driving force behind the company's efforts to expand its clinical research and build a strong body of evidence supporting the efficacy of its technology. As the President and CEO of CVRx, Hykes is responsible for overseeing the company's overall strategy, operations, and growth initiatives. He works closely with the executive team to ensure that CVRx remains at the forefront of innovation in the cardiovascular device space. Hykes' leadership style emphasizes collaboration, accountability, and a patient-centric approach, which has fostered a strong corporate culture and positioned CVRx for long-term success in improving the lives of patients with cardiovascular diseases.